Skip to main content

Opioid Epidemic Week Part Two: CDC Issues New Guidelines on Opioid Prescribing

Needless to say, the opioid epidemic has caused a major clash of government agencies, drug companies, pain care advocates and other medical organizations.  Some US states have passed legislation in response to the crisis.

In the last few weeks, the CDC--a governmental agency that oversees public health matters--released its own guidelines for pain management.  The guidelines are non-binding but represent a sweeping change to the way pain is addressed in the American medical community.  Some highlights from this policy change include:

  • opioid medications should not be considered "first line therapy"
  • three days or less of opioid medication should be sufficient for most cases, excluding cancer patients, or those under palliative or end of life care
  • dosage and prescribing limitations for prescribers
  • review of dosages and patient goals and outcomes of therapy during patient care visits
  • prescriber monitoring of patient history/pattern of drug usage through established databases
This is not the first time--but of course many of the key players in pain management are not happy with the policy. For one thing, Purdue Pharmaceuticals, the makers of OxyContin® are dismayed by this move. Some others have complained that alternatives to medication, such as massage or yoga, may not be covered by health insurance providers.  Advocates for cancer survivors argue that many patients may have pain even after cancer cure, and as such should be allowed to use pain medications chronically if need be.

And so, the story continues...

You can read more about the CDC guidelines and the continuing controversy by clicking here.

Sources: The Guardian; Wikimedia


Popular posts from this blog

Herpes As A Helper?

If you've ever had shingles, or known anyone that has experienced it, you probably know that chronic pain can persist following the initial attack (post herpetic neuralgia).  This is because the herpes virus seems to have an affinity for nerve cells.  And while it's not fun to have shingles or post herpetic neuralgia, the herpes virus may be a key in future development of delivery systems for pain management treatments.

Here's the deal--since Herpes simplex has an affinity for nerve cells, researchers are looking a genetically modified, safer version of the virus to deliver genetic material to damaged nerves.  In simple terms, once the genetic material reaches these nerve cells, it will hopefully encode these nerves to ultimately inhibit pain signals.  Animal studies and clinical trials in cancer patients have been encouraging thus far.

This is one of those developments that makes me believe that there is hope for those in chronic pain. Along with so many other exciting d…

Beware Of The Tick!

It's tick season, everyone! And while we all know about Lyme Disease and its lingering effects, a new problem has entered the scene. According to the CDC, the Powassan virus is another tick-borne disease that has recently been recognized. The CDC says symptoms become apparent anywhere from one week to one month after infection. Symptoms include vomiting, weakness, confusion, loss of coordination, problems with speech and seizures. Approximately half of those infected by this virus have permanent neurological symptoms, which can include muscle wasting, problems with memory, and recurrent headaches.

Many people who have been infected with Powassan virus required hospitalization and sometimes even respiratory support (i.e., a respirator). Treatment is focused on supportive measures. In the meantime, preventive measures are the best way to avoid Lyme disease, Powassan virus, or any other tick-borne virus.  You can read more about preventive measures by clicking here.


The Knee Bone's Connected To The Leg Bone....

Two recent studies have brought a not-so-novel concept into the limelight-the concept being that people who present with knee pain often develop pain in other parts of their bodies.  These studies, known as the Multicenter Osteoarthritis Study (MOST) and the Osteoarthritis Initiative (OAI), were assessed by a Clinical Epidemiology Team as Boston University School of Medicine in an effort to find preventive strategies to combat this trend.

The authors suggest that knee pain may cause individuals to alter their gait in an effort to compensate for their discomfort. In doing so, the alignment of other body joints is altered, and this may be the cause of secondary joint pain, especially hips and ankles. The authors go on to say that the pain in these secondary sites is not necessarily osteoarthritis--perhaps bursitis or some other injury.

Osteoarthritis is a result of wear and tear in the joints.  We may not be able to completely eliminate osteoarthritis from occurring, but some common se…